Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02312739 · ClinicalTrials.gov registry record · NA
Nitrous Oxide for Pain Management During In-office Transcervical Sterilization
A NA study of Contraception and Inhalation of Nitrous Oxide, sponsored by University of New Mexi.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT02312739: Completed NA study of Contraception and Inhalation of Nitrous Oxide, sponsored by University of New Mexi.
NCT02312739 is a NA study of Contraception and Inhalation of Nitrous Oxide that has completed, run by University of New Mexi. The registered enrollment target is 72 participants, below the 454-participant average among 72 other Contraception trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02312739, a NA study of Contraception and Inhalation of Nitrous Oxide, has completed, sponsored by University of New Mexi.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized, double blind study that aims to measure the difference in maximum pain experienced during in-office transcervical sterilization (Essure®) for women receiving either inhaled nitrous oxide or standard oral analgesia (Vicodin and Lorazepam) with inhaled oxygen. The investigators hypothesize that inhaled nitrous oxide will reduce the pain experienced more than standard oral medications in women undergoing in-office transcervical sterilization.
Primary Outcome
Pain is assessed using a 0-100mm VAS with anchors 0 equals no pain and 100 equals worst pain imaginable. It is taken at baseline, after paracervical block injection and after placement of second Essure® coil. A final pain assessment is done prior to discharge.
Conditions Studied
Interventions
- OTHER Oxygen
- PROCEDURE In-office Transcervical Sterilization (Essure®)
- DRUG Standard Oral pain medications
- DRUG Intramuscular Ketorolac
- DRUG Placebo pills
Study Locations (1)
New Mexico
- UNM Center for Reproductive Health - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2014-02 |
| Est. Completion | 2015-03 |
| Phase | NA |
What the finished NCT02312739 record still lists
NCT02312739 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 454-participant average among 72 other Contraception trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Contraception appearing as the primary indexed condition, and to 5 interventions - of which Oxygen is the first listed.
NCT02312739 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT02312739 about?
NCT02312739 is a clinical study titled "Nitrous Oxide for Pain Management During In-office Transcervical Sterilization". This is a randomized, double blind study that aims to measure the difference in maximum pain experienced during in-office transcervical sterilization (Essure®) for women receiving either inhaled nitrous oxide or standard oral analgesia (Vicodin and Lorazepam) with inhaled oxygen. The investigators ...
What is the current status of trial NCT02312739?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2014-02. Estimated completion is 2015-03.
What conditions does trial NCT02312739 study?
This clinical trial studies the following conditions: Contraception, Inhalation of Nitrous Oxide.
What interventions are being tested in trial NCT02312739?
The interventions under investigation include: Oxygen (OTHER), In-office Transcervical Sterilization (Essure®) (PROCEDURE), Standard Oral pain medications (DRUG), Intramuscular Ketorolac (DRUG), Placebo pills (DRUG).
Who is sponsoring clinical trial NCT02312739?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02312739 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02312739's enrollment target sits among peer trials
72 46th of 72 higher than 27 of 72 other Contraception trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Contraception trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
-
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
RECRUITING · NA
-
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
RECRUITING · NA
-
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
RECRUITING · NA
-
Contraceptive Efficacy Study of Ovaprene
RECRUITING · NA
-
Intervening on Women's Health for Rural Young Cancer Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia